The midcap fund added 7.43 lakh shares of United Breweries and approximately 5.87 lakh shares of Premier Energies to its portfolio during the mentioned period.
13th Mar 2025 7:00 am RNS Transaction in Own Shares 12th Mar 2025 7:00 am RNS Transaction in Own Shares 11th Mar 2025 7:00 am RNS Transaction in Own Shares 10th Mar ...
BANGALORE, India, March 10, 2025 /PRNewswire/ -- Syngene International Limited ('Syngene'), a global contract research, development, and manufacturing organization ...
GSK’s prescription antibiotic Augmentin retained its spot as the best-selling brand in the Indian market in February, followed by USV’s oral anti-diabetic, Glycomet GP1. Notably, Himalaya’s Liv.
GSK (GSK) announced the US Food and Drug Administration, FDA, has accepted for review the Biologics License Application, BLA, for the use of depemokimab in two indications. The proposed ...
With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its own. The British Big Pharma has filed depemokimab for FDA approval ...
The Indian Institute of Science (IISc) Bangalore has opened applications for the inaugural session of the Research Science Initiative-India (RSI-India), a prestigious summer research programme for ...
Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big Pharma after GSK (NYSE:GSK) to revise DEI initiatives amid the Trump ...
For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it revealed (PDF) that Walmsley took a 16% pay cut in 2024, it also laid out a new compensation ...
UC Inclusive Credit Private Limited has sanctioned Term Loan of Rs. 8,00,00,000/- (Rupees Eight Crores Only) to Akme Fintrade (India) Limited. Shares of Akme Fintrade India Limited was last ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK has proposed increasing pay for its chief executive Emma Walmsley to as much as £21.6mn a year ...
LONDON, Feb 27 (Reuters) - British drugmaker GSK (GSK.L), opens new tab will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such ...